Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1841935

Celtic Pharmaceutical Holdings L.P. - Product Pipeline Review - Q1 2011

Description:

Celtic Pharmaceutical Holdings L.P. – Product Pipeline Review – Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “Celtic Pharmaceutical Holdings L.P. - Product Pipeline Review - Q1 2011” provides data on the Celtic Pharmaceutical Holdings L.P.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Celtic Pharmaceutical Holdings L.P.’s corporate website, SEC filings, investor presentations and featured press releases, both from Celtic Pharmaceutical Holdings L.P. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Celtic Pharmaceutical Holdings L.P. - Brief Celtic Pharmaceutical Holdings L.P. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Celtic Pharmaceutical Holdings L.P. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Celtic Pharmaceutical Holdings L.P. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Celtic Pharmaceutical Holdings L.P.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Celtic Pharmaceutical Holdings L.P.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Celtic Pharmaceutical Holdings L.P. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Celtic Pharmaceutical Holdings L.P.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Celtic Pharmaceutical Holdings L.P..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Celtic Pharmaceutical Holdings L.P. and identify potential opportunities in those areas.

Contents:

List of Tables
List of Figures
Celtic Pharmaceutical Holdings L.P. Snapshot
Celtic Pharmaceutical Holdings L.P. Overview
Key Information
Key Facts
Celtic Pharmaceutical Holdings L.P. – Research and Development Overview
Key Therapeutic Areas
Celtic Pharmaceutical Holdings L.P. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Celtic Pharmaceutical Holdings L.P. – Pipeline Products Glance
Celtic Pharmaceutical Holdings L.P. – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Celtic Pharmaceutical Holdings L.P. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Celtic Pharmaceutical Holdings L.P.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Celtic Pharmaceutical Holdings L.P. – Drug Profiles
TDT-067
Product Description
Mechanism of Action
R&D Progress
Xerecept
Product Description
Mechanism of Action
R&D Progress
TA-CD
Product Description
Mechanism of Action
R&D Progress
TA-NIC
Product Description
Mechanism of Action
R&D Progress
IDEA-077
Product Description
Mechanism of Action
R&D Progress
Celtic Pharmaceutical Holdings L.P. – Pipeline Analysis
Celtic Pharmaceutical Holdings L.P. – Pipeline Products by Therapeutic Class
Celtic Pharmaceutical Holdings L.P. - Pipeline Products By Target
Celtic Pharmaceutical Holdings L.P. – Pipeline Products by Route of Administration
Celtic Pharmaceutical Holdings L.P. – Pipeline Products by Molecule Type
Celtic Pharmaceutical Holdings L.P. – Recent Pipeline Updates
Celtic Pharmaceutical Holdings L.P. - Dormant Projects
Celtic Pharmaceutical Holdings L.P. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
TA-HSV
TransMID
Celtic Pharmaceutical Holdings L.P. – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Celtic Pharmaceutical Holdings L.P. – Pipeline by Therapy Area and Indication, 2011
Celtic Pharmaceutical Holdings L.P. – Pipeline by Stage of Development, 2011
Celtic Pharmaceutical Holdings L.P. – Monotherapy Products in Pipeline, 2011
Celtic Pharmaceutical Holdings L.P. – Phase III, 2011
Celtic Pharmaceutical Holdings L.P. - Phase II, 2011
Celtic Pharmaceutical Holdings L.P. - Pipeline By Therapeutic Class, 2011
Celtic Pharmaceutical Holdings L.P. - Pipeline By Target, 2011
Celtic Pharmaceutical Holdings L.P. – Pipeline By Route of Administration, 2011
Celtic Pharmaceutical Holdings L.P. – Pipeline By Molecule Type, 2011
Celtic Pharmaceutical Holdings L.P. – Recent Pipeline Updates, 2011
Celtic Pharmaceutical Holdings L.P. - Dormant Developmental Projects, 2010
Celtic Pharmaceutical Holdings L.P. - Discontinued Pipeline Products, 2010

List of Figures
Celtic Pharmaceutical Holdings L.P. – Pipeline by Therapy Area and Indication, 2011
Celtic Pharmaceutical Holdings L.P. – Pipeline by Stage of Development, 2011
Celtic Pharmaceutical Holdings L.P. – Monotherapy Products in Pipeline, 2011
Celtic Pharmaceutical Holdings L.P. – Pipeline By Therapeutic Class, 2011
Celtic Pharmaceutical Holdings L.P. - Pipeline By Target, 2011
Celtic Pharmaceutical Holdings L.P. – Pipeline By Route of Administration, 2011
Celtic Pharmaceutical Holdings L.P. – Pipeline By Molecule Type, 2011

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/1582661

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2

Printed Tuesday, May 21, 2013
8:14:21 AM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

Celtic Pharmaceutical Holdings L.P. - Product Pipeline Review - Q1 2011

Web Address

http://www.researchandmarkets.com/reports/1841935

Office Code

OC8DIQSQOURTYZ

Report Formats

Please enter the quantity of the report format you require.

Format	Quantity	Price
Electronic (PDF) - Single User		EURO€ 384.00
Electronic (PDF) - Site License		EURO€ 769.00
Electronic (PDF) - Enterprisewide		EURO€ 1,153.00

Contact information

Please enter all the information below in block capitals.

                Title:
            
                    Mr
                    
                    Mrs
                    
                    Dr
                    
                    Miss
                    
                    Ms
                    
                    Prof
                    
                First Name:
            
                Last Name:
                
                Email Address:
            
                Job Title:
            
                Organisation:
            
                Address:
            
                City:
            
                Postal / Zip Code:	
            
                Country:	
            
                Phone Number:	
            
                Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2

Printed Tuesday, May 21, 2013
8:14:21 AM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:

Cardholder's Signature:

Expiry Date:

Card Number:

CVV Security Code:

Issue date:

(Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:

Account Number:

83313083

Sort Code:

98-53-30

Swift Code:

ULSBIE2D

IBAN Number:

IE78ULSB98533083313083

Bank Address:

Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Printer Friendly

Celtic Pharmaceutical Holdings L.P. - Product Pipeline Review - Q1 2011

Fax order form

Order information

Product name

Web Address

Office Code

Report Formats

Contact information

Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Payment information

Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)